Trends in Diabetic Retinopathy, Visual Acuity, and Treatment Outcomes for Patients Living With Diabetes in a Fundus Photograph–Based Diabetic Retinopathy Screening Program in Bangladesh
Open accessAbstract
Importance: Diabetic retinopathy (DR) is the leading cause of low vision among working-age adults. An estimated 6.9 million people in Bangladesh were living with diabetes in 2017, which is projected to increase to more than 10 million people in 2025. Currently, no standardized and/or large-scale DR screening program exists in Bangladesh. Objective: To develop a novel fundus photograph-based eye screening model for early detection of DR to prevent vision loss in Bangladeshi individuals with diabetes. Design, Setting, and Participants: In this cross-sectional study, 49 264 patients with diabetes underwent opportunistic eye screening at 2 eye hospitals and 1 diabetic hospital in Bangladesh between June 1, 2010, and September 30, 2017. The data set was analyzed from April 8 to December 30, 2018. Technicians were trained to obtain 2-field digital fundus photographs and to grade each according to a standardized DR severity scale. Each patient was counseled and triaged for treatment using defined DR referral criteria. Main Outcomes and Measures: Primary DR grading outcomes, visual acuity, and treatment outcomes. Results: A total of 49 264 patients (54.3% male; mean [SD] age, 50.8 [12.3] years) underwent DR screening during a 7-year period. The DR prevalence rate across all 3 sites was 33% (95% CI, 33%-33%). Prevalence rates varied by center (Chittagong, 64.6% [95% CI, 64.0%-65.0%]; Dhaka, 39.8% [95% CI, 39.0%-41.0%]; and Feni, 13.0% [95% CI, 13.0%-14.0%]). Across all age groups, male patients were at higher risk of prevalent DR than female patients (odds ratio, 1.99; 95% CI, 1.90-2.07). The prevalence was 3.9% for preproliferative DR, 7.8% for proliferative DR, and 19.2% for maculopathy. Individuals with DR had significantly worse visual acuity than those with no DR (best-corrected visual acuity, 0.35 vs 0.21 logMAR; P < .001). The rate of moderate visual impairment was 12.2%, and the rate of blindness was 2.5%. Primary treatments included laser photocoagulation (n = 1637), intravitreal injection (n = 1440), and vitrectomy (n = 309). Conclusions and Relevance: Screening Bangladeshi individuals known to have diabetes using fundus photography identified large numbers of patients with sight-threatening proliferative DR, maculopathy, and visual impairment or blindness. Expansion of eye screening services in Bangladesh is warranted as part of a national government eye care and diabetes health policy.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Remote grading of retinal images was widely utilized, with 18 out of 30 studies relying on this approach.
“Remote grading of retinal images is widely utilized, with 18 out of 30 studies relying on this approach [10, 15, 16, 18, 21–27, 29–35, 37]”
From Diabetic retinopathy screening model in low and middle-income countries: a scoping review (2025) · cites this paper as [25]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., Vandenbroucke, J. P., & Initiative, F. T. S. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040296 · Cited by 23,020 · see citing works
Flagged first, then by citations
Research works printed but not linked: 19
- [1]Amos AF, McCarty DJ, Zimmet P The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med. 1997; 14(suppl 5):-. doi: 10.1002/(SICI)1096-9136(199712)14:5+<S7::AID-DIA522>3.3.CO;2-I 9450510 · DOI
- [2]Yau JW, Rogers SL, Kawasaki R,; Meta-Analysis for Eye Disease (META-EYE) Study Group Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012; 35(3): 556- 564. doi: 10.2337/dc11-1909 22301125 PMC3322721 · DOI · Paper page
- [3]International Diabetes Federation IDF diabetes atlas, 8th edition. http://www.diabetesatlas.org/resources/2017-atlas.html. Published 2017. Accessed January 30, 2019.
- [4]Pizzarello L, Abiose A, Ffytche T, VISION 2020: the Right to Sight: a global initiative to eliminate avoidable blindness. Arch Ophthalmol. 2004; 122(4): 615- 620. doi: 10.1001/archopht.122.4.615 15078680 · DOI
- [5]Porta M, Bandello F Diabetic retinopathy: a clinical update. Diabetologia. 2002; 45(12): 1617- 1634. doi: 10.1007/s00125-002-0990-7 12488951 · DOI
- [6]Zimmet P The burden of type 2 diabetes: are we doing enough? Diabetes Metab. 2003; 29(4, pt 2): S9- S18. doi: 10.1016/S1262-3636(03)72783-9 14502096 PMC7129589 · DOI
- [8]Wild S, Roglic G, Green A, Sicree R, King H Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004; 27(5): 1047- 1053. doi: 10.2337/diacare.27.5.1047 15111519 · DOI · Paper page
- [9]Scanlon PH The English National Screening Programme for sight-threatening diabetic retinopathy. J Med Screen. 2008; 15(1): 1- 4. doi: 10.1258/jms.2008.008015 18416946 · DOI
- [11]Scanlon PH The English National Screening Programme for diabetic retinopathy 2003-2016. Acta Diabetol. 2017; 54(6): 515- 525. doi: 10.1007/s00592-017-0974-1 28224275 PMC5429356 · DOI
- [13]Wändell PE, Carlsson AC Gender differences and time trends in incidence and prevalence of type 2 diabetes in Sweden—a model explaining the diabetes epidemic worldwide today? Diabetes Res Clin Pract. 2014; 106(3): e90- e92. doi: 10.1016/j.diabres.2014.09.013 25451899 · DOI
- [14]Lin JC, Shau WY, Lai MS Sex- and age-specific prevalence and incidence rates of sight-threatening diabetic retinopathy in Taiwan. JAMA Ophthalmol. 2014; 132(8): 922- 928. doi: 10.1001/jamaophthalmol.2014.859 24809869 · DOI
- [15]Al-Rubeaan K, Abu El-Asrar AM, Youssef AM, Diabetic retinopathy and its risk factors in a society with a type 2 diabetes epidemic: a Saudi National Diabetes Registry-based study. Acta Ophthalmol. 2015; 93(2): e140- e147. doi: 10.1111/aos.12532 25270515 · DOI · Paper page
- [16]Thomas RL, Dunstan F, Luzio SD, Incidence of diabetic retinopathy in people with type 2 diabetes mellitus attending the Diabetic Retinopathy Screening Service for Wales: retrospective analysis. BMJ. 2012; 344: e874. doi: 10.1136/bmj.e874 22362115 PMC3284424 · DOI
- [17]Varma R, Choudhury F, Klein R, Chung J, Torres M, Azen SP; Los Angeles Latino Eye Study Group Four-year incidence and progression of diabetic retinopathy and macular edema: the Los Angeles Latino Eye Study. Am J Ophthalmol. 2010; 149(5): 752- 61.e1, 3. doi: 10.1016/j.ajo.2009.11.014 20149342 PMC2905589 · DOI
- [18]Huang OS, Tay WT, Ong PG, Prevalence and determinants of undiagnosed diabetic retinopathy and vision-threatening retinopathy in a multiethnic Asian cohort: the Singapore Epidemiology of Eye Diseases (SEED) study. Br J Ophthalmol. 2015; 99(12): 1614- 1621. doi: 10.1136/bjophthalmol-2014-306492 25953847 · DOI
- [19]Klein R, Klein BE, Moss SE, Cruickshanks KJ The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII, the 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology. 1998; 105(10): 1801- 1815. doi: 10.1016/S0161-6420(98)91020-X 9787347 · DOI
- [20]Jayawardena R, Ranasinghe P, Byrne NM, Soares MJ, Katulanda P, Hills AP Prevalence and trends of the diabetes epidemic in South Asia: a systematic review and meta-analysis. BMC Public Health. 2012; 12: 380. doi: 10.1186/1471-2458-12-380 22630043 PMC3447674 · DOI
- [21]Islam JY, Zaman MM, Bhuiyan MR, Haq SA, Ahmed S, Al-Qadir AZ Prevalence and determinants of hyperglycaemia among adults in Bangladesh: results from a population-based national survey. BMJ Open. 2019; 9(7): e029674. doi: 10.1136/bmjopen-2019-029674 31345979 PMC6661587 · DOI
- [22]Dineen BP, Bourne RR, Ali SM, Huq DM, Johnson GJ Prevalence and causes of blindness and visual impairment in Bangladeshi adults: results of the National Blindness and Low Vision Survey of Bangladesh. Br J Ophthalmol. 2003; 87(7): 820- 828. doi: 10.1136/bjo.87.7.820 12812875 PMC1771736 · DOI
Cited by
Sorted by citations
Curran, K., Piyasena, P., Congdon, N., Duke, L., Malanda, B., & Peto, T. (2023) · Health Research Policy and Systems · doi:10.1186/s12961-022-00940-0 · Cited by 21 · see citing works
Diabetic retinopathy screening model in low and middle-income countries: a scoping review
Lestari, Y. D., Sitompul, R., Widyahening, I. S., Tahapary, D. L., Yusuf, P. A., Sasongko, M. B., Riono, P., Nursakina, Y., & Alexandra, G. (2025) · BMC Public Health · doi:10.1186/s12889-025-25543-6 · Cited by 11 · see citing works
- Authors
- Muqit, M. M. K., Kourgialis, N., Jackson-deGraffenried, M., Talukder, Z., Khetran, E. R., Rahman, A., Chan, W. O., Chowdury, F. A., Nag, D., Ahmad, J., & Friedman, D. S.
- Affiliations
- National Health Service (GB)
- Helen Keller International (US)
- Helen Keller International, Dhaka, Bangladesh
- The University of Adelaide (AU)
- Retina Service, National Institute of Ophthalmology and Hospital, Dhaka, Bangladesh
- Retina Service, Chittagong Eye Infirmary and Training Complex, Chittagong, Bangladesh
- Massachusetts Eye and Ear Infirmary (US)
- Corresponding author
- Muqit, Mahiul M. K.
- Venue
- JAMA Network Open
- Publisher
- American Medical Association (AMA)
- Published
- 2019-11-27
- Volume
- 2
- Issue
- 11
- Pages
- e1916285
- ISSN
- 2574-3805 (ISSN-L)
- PMC
- PMC6902843
- OpenAlex
- W2991417312
- Cited by
- 28
- References
- 1
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 4 · 2023: 8 · 2022: 4 · 2021: 7
- FWCI
- 2.70
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- JAMA Network Open (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- National Institute for Health and Care Research
- Moorfields Eye Hospital NHS Foundation Trust
- World Diabetes Foundation
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
- Health Sciences › Medicine › Ophthalmology › Ophthalmology and Visual Health Research
- Keywords
- diabetic retinopathy, diabetic retinopathy screening, fundus photography, visual acuity, diabetic maculopathy, proliferative diabetic retinopathy, preproliferative diabetic retinopathy, Bangladesh, treatment outcomes, retinopathy grading, low vision
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Bangladesh, Child, Cross-Sectional Studies, Diabetic Retinopathy, Female, Fundus Oculi, Humans, Male, Mass Screening, Middle Aged, Visual Acuity, Prevalence, Treatment Outcome, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review